Medical/Pharmaceuticals
ANGUS ANNOUNCES CORPORATE REBRANDING, WILL CHANGE NAME TO "ADVANCION"
New name and brand reflect Company's strategic transformation into a leading global producer of specialty ingredients for Life Sciences, Personal Care and other essential markets BUFFALO GROVE, Ill., May 4, 2023 /PRNewswire/ -- ANGUS Chemical Company ("ANGUS" or "Company") today unveiled a new n...
2023-05-04 21:00
5227
Cambridge Infinitus Research Centre Launches World Leading AI-based Technology Platform ERnet for Studies of Cellular Health
GUANGZHOU, China, May 4, 2023 /PRNewswire/ -- The Cambridge Infinitus Research Centre (CIRCE) was officially established in 2015 as Infinitus' first international scientific research collaboration platform outside ofChina. CIRCE recently achieved another scientific and technological breakthrough ...
2023-05-04 16:00
3891
First Subject Enrolled in Boan Biotech's International Multi-Center Phase 3 Clinical Study for Its Denosumab BA6101 & BA1102
YANTAI, China, May 4, 2023 /PRNewswire/ -- Boan Biotech today announced that an international multi-center Phase 3 clinical study for its in-house developed Denosumab Injection (BA6101; BA1102) has been initiated inEurope, the United States, and Japan, and recently the first patient in (FPI) was ...
2023-05-04 14:40
5750
European Wellness Joint Research with Heidelberg University in Journal Publication
HEIDELBERG, Germany, May 4, 2023 /PRNewswire/ -- European Wellness Academy (EWA), a wholly owned subsidiary European Wellness Biomedical Group (EW Group) has entered into a cooperation agreement with Heidelberg University in medical research. The research project, titled "A Tendon Specific Double...
2023-05-04 13:39
3393
George Clinical Applauded by Frost & Sullivan for Its Competitive Differentiation and Leadership in Strategy Execution in the Asia Pacific region
George Clinical cares for its employees, enables business continuity, and builds on its expertise, giving it a competitive industry advantage. SAN ANTONIO, May 4, 2023 /PRNewswire/ -- Frost & Sullivan studied the contract research organization industry and, based on its findings, recognizes Georg...
2023-05-04 11:00
2634
Annalise.ai grows global footprint with expansion into India
Leading global AI radiology company opens new office in Chennai CHENNAI, India, May 4, 2023 /PRNewswire/ -- Annalise.ai, one of the world's largest artificial intelligence (AI) radiology companies, has today announced it is continuing its global expansion with the opening of the Annalise India ...
2023-05-04 10:56
3428
Alma Lasers' Global Expansion and Vision for Holistic Wellness Solutions Unveiled at Fifth 'Alma Academy' in Italy, Attended by Physicians from 46 Countries
CAESAREA, Israel, May 4, 2023 /PRNewswire/ -- Alma Lasers
2023-05-04 07:22
4308
Formus Labs, Pioneering Developer of AI-Powered 3D Orthopedic Surgery Planning Technology, Receives FDA Clearance
Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D surgical plans that optimize the preoperative (pre-op) planning process WARSAW, Ind., May 4, 2023 /PRNewswire/ -- Formus Labs today announced it has received 510(k) clearance from the United States Food ...
2023-05-04 06:18
2799
Aktiia's Continual Blood Pressure Solution Shows Comparable Results to ABPM
NEUCHÂTEL, Switzerland, May 4, 2023 /PRNewswire/ -- Aktiia, a health tech startup transforming hypertension care, has announced promising results from a preliminary study comparing their cuff-less and continual blood pressure monitor with traditional ambulatory blood pressure monitors (ABPM). The...
2023-05-04 00:00
3091
SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector
ZUG, Switerland, May 3, 2023 /PRNewswire/ -- SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for infl...
2023-05-03 22:43
4368
Lantern Pharma Selects REPROCELL USA to Provide Support for the Phase 2 Harmonic™ Clinical Trial
BELTSVILLE, Md., May 3, 2023 /PRNewswire/ -- Reprocell USA, a CRO, has been awarded a contract to provide support for Lantern Pharma's Phase 2 clinical trial entitled "A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers with Advanced Lung Adenocarcinoma (HARMONIC)". The Harmonic™ s...
2023-05-03 21:00
2714
Healthcare Veteran, Zach Henderson to lead Global Kinetics as CEO
CHARLOTTE, N.C. and MELBOURNE, Australia, May 3, 2023 /PRNewswire/ -- Global Kinetics, the global leader in digital health solutions for neurological conditions, today announced the appointment of Zach Henderson as its new Chief Executive Officer. Zach will also join the Board of Directors. Za...
2023-05-03 21:00
3929
LenioBio GmbH Announces New CEO
DUSSELDORF, Germany, May 3, 2023 /PRNewswire/ -- LenioBio GmbH, the Düsseldorf-based cell-free protein expression company, has announced that its founder and CEO, Dr.Remberto Martis, will be stepping down as CEO and has proudly named his successor as André Goerke, startingJune 1st, 2023. Andr...
2023-05-03 20:00
4304
Chula Researchers Develop Rapid MTB Strip Test for Tuberculosis
Lecturers of the Faculty of Allied Health Sciences, Chulalongkorn University have developed the MTB Strip Test Kit for Tuberculosis (TB) diagnosis that's accurate and easy to use, guaranteed by the 2023 Invention Award from the National Research Council of Thailand (NRCT) -- Another hope to reduce...
2023-05-03 11:34
4915
Merck Signs MoU with Ministry of Trade, Industry & Energy and Daejeon City for New Asia Pacific BioProcessing Production Center in South Korea
* MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem * Proposed bioprocessing facility to be based in Daejeon City * Further collaboration aims to support emerging biotech companies and academic research DAEJEON CITY, South Korea, May 3, 2023 /PRNe...
2023-05-03 10:00
4411
Sourcing Ideal Medical Device Materials: Experience ICP DAS - BMP medical-grade TPUs at 2023 CMEF Shanghai, China
HSINCHU, May 3, 2023 /PRNewswire/ -- Material "safety" and "quality" are paramount to medical device manufacturers. Therefore, ICP DAS - BMP (Biomedical Polymers), aTaiwan medical-grade TPU (thermoplastic polyurethane) supplier, will partake in CMEF (ICMD) to further make known our highly-stable ...
2023-05-03 09:46
4528
Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients
SUZHOU, China, May 3, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces that the enrollment of ...
2023-05-03 08:00
5222
ZEISS Presents New Surgical Workflow Innovations at ASCRS
New products help doctors diagnose and treat patients within the cataract and corneal refractive workflows. JENA, Germany and DUBLIN, Calif., May 3, 2023 /PRNewswire/ -- ZEISS Medical Technology will showcase new surgical workflow innovations at the American Society of Cataract and Refractive Su...
2023-05-03 02:09
3418
Turacoz Forges Ahead with Veeva Content Certification & Training for Professionals
UTRECHT, Netherlands and NEW DELHI, May 3, 2023 /PRNewswire/ -- Turacoz Healthcare Solutions has been making strides in the field of medical communications using cutting-edge technologies. The demand for high-quality scientific and medical writing is increasing, and Turacoz is leading the way in ...
2023-05-03 01:55
3972
Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis
The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints trended favorably for sparsentan Treatment with sparsentan resulted in a reduction of proteinuria that was sustained through 108 weeks of treatment S...
2023-05-03 00:22
4268
Week's Top Stories
Most Reposted
Visa returns as title sponsor for 2026 MAMA AWARDS; Visa Presale registration begins 13 October
[Picked up by 310 media titles]
2026-10-13 10:00
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 292 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 281 media titles]
2026-10-15 10:00Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 279 media titles]
2026-10-15 12:59
New Asia Forum Targets US$30 Billion in Investment into the New Asia at Its Inaugural Edition in Bali
[Picked up by 275 media titles]
2026-10-09 13:21Most Read
Amap and Sands China mark the delivery of the first Tutu robots, with expected indoor navigation and 3D resort previews
2026-10-10 16:43
15612
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
13816